Diane L. Cafritz - 30 Jun 2025 Form 4 Insider Report for CARMAX INC (KMX)

Reporting relationship: EVP, Chief Innov & People Off
Issuer ticker: KMX
Reported as of: 30 Jun 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 02 Jul 2025, 16:23:00 UTC
Prior SEC filing: 05 May 2025
Next SEC filing: 23 Apr 2026
Source filing: View source filing
Reporting owner signature: Christine Carter, attorney-in-fact

Key filing fact

Diane L. Cafritz filed Form 4 for CARMAX INC (KMX) on 02 Jul 2025.

Key facts

This page summarizes Diane L. Cafritz's Form 4 filing for CARMAX INC (KMX).
2 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 02 Jul 2025, 16:23.

Change

Previous filing in this sequence was filed on 05 May 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001702741 Primary reporting owner

Cafritz Diane L

Relationship: EVP, Chief Innov & People Off
Address: 12800 TUCKAHOE CREEK PARKWAY, RICHMOND
Signature: Christine Carter, attorney-in-fact
Signature date: 02 Jul 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

KMX transaction Derivative

Restricted Stock Units

Award

Transaction value: $0
Shares: +1,066
Change %
Price: $0.000000
Shares after: 1,066
Date: 30 Jun 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount
Exercise price
Footnotes: F1, F2

KMX transaction Derivative

Stock Options (Right to Buy)

Award

Transaction value: $0
Shares: +3,685
Change %
Price: $0.000000
Shares after: 3,685
Date: 30 Jun 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 3,685
Exercise price: $67.21
Footnotes: F3, F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Shares of Company common stock will be issued to the Reporting Person following vesting of the restricted stock units, which are referred to by the Company as market stock units (MSUs), in accordance with the terms of the Form of Notice of Market Stock Unit Grant filed as Exhibit 10.22 to the Company's Annual Report on Form 10-K filed on April 15, 2024. The minimum number of shares of Company common stock that will be issued to the Reporting Person at payment is zero, and the maximum number of shares of Company common stock that will be issued at payment is two times the number of MSUs.

Footnote F2

The restricted stock units shall vest on June 30, 2028.

Footnote F3

The stock options were granted in tandem with stock appreciation rights (SARS). Accordingly, the exercise of one results in the surrender to the Company of the other. The SARS become exercisable only following a change in control of the Company as set forth in the Company's 2002 Stock Incentive Plan, as amended and restated. Once exercisable, the SARS would entitle the Reporting Person to receive the cash value of the options in lieu of exercising the options.

Footnote F4

The stock options become exercisable with respect to one-fourth of the underlying shares of Common Stock on each of June 30, 2026, June 30, 2027, June 30, 2028 and June 30, 2029.